To the Editor,

 {#jcla23412-sec-0001}

The novel coronavirus disease 2019 (COVID‐19) has given rise to a worldwide pandemic. As of May 15, 2020, according to the latest data report from the World Health Organization, there have been 4 338 658 confirmed cases worldwide, resulting in 297 119 deaths.[^1^](#jcla23412-bib-0001){ref-type="ref"} Previous papers have reported the abnormalities of albumin values and total bilirubin values among COVID‐19 patients.[^2^](#jcla23412-bib-0002){ref-type="ref"} We aimed to investigate the differences in albumin values and total bilirubin values in the progression of COVID‐19 patients and to provide evidence for clinical treatment.

The databases of PubMed, Web of Science, and medRxiv were searched for related studies up to May 16, 2020. Search terms included the keywords: (\["coronavirus" or "COVID‐19" or "SARS‐CoV‐2" or "2019 nCoV"\] and "laboratory"). There is no language restriction. Articles were screened by title, abstract, and full texts for the data. All articles that reported information on the albumin values or total bilirubin values in COVID‐19 patients with or without the severe disease (ie, ICU admission or acute respiratory distress syndrome) or between non‐survivors and survivors were included. The *I* ^2^ test was applied to assess the statistical heterogeneity among studies. The weighted mean difference (WMD) and 95% confidence interval (CI) were calculated to estimate the pooled effects of albumin values. The standardized mean difference (SMD) and 95% CI were calculated to estimate the pooled effects of total bilirubin values owing to different detection methods and data representation unit among studies.[^3^](#jcla23412-bib-0003){ref-type="ref"} The sample size, median, and interquartile range (IQR) were used to estimate the mean and standard deviation.[^4^](#jcla23412-bib-0004){ref-type="ref"} Egger\'s and Begg\'s tests were used to assess the publication bias. All statistical analyses were conducted using *Stata* 11 (StataCorp) software package, and *P* \< .05 was considered significant.

Initially, a total of 2165 studies were identified in the search. By reading titles and abstracts, 2077 studies were excluded. By reading the full texts, 64 studies were excluded owing to that they did not report albumin values or total bilirubin values. At last, 24 studies were enrolled in our meta‐analysis.[^5^](#jcla23412-bib-0005){ref-type="ref"}, [^6^](#jcla23412-bib-0006){ref-type="ref"}, [^7^](#jcla23412-bib-0007){ref-type="ref"}, [^8^](#jcla23412-bib-0008){ref-type="ref"}, [^9^](#jcla23412-bib-0009){ref-type="ref"}, [^10^](#jcla23412-bib-0010){ref-type="ref"}, [^11^](#jcla23412-bib-0011){ref-type="ref"}, [^12^](#jcla23412-bib-0012){ref-type="ref"}, [^13^](#jcla23412-bib-0013){ref-type="ref"}, [^14^](#jcla23412-bib-0014){ref-type="ref"}, [^15^](#jcla23412-bib-0015){ref-type="ref"}, [^16^](#jcla23412-bib-0016){ref-type="ref"}, [^17^](#jcla23412-bib-0017){ref-type="ref"}, [^18^](#jcla23412-bib-0018){ref-type="ref"}, [^19^](#jcla23412-bib-0019){ref-type="ref"}, [^20^](#jcla23412-bib-0020){ref-type="ref"}, [^21^](#jcla23412-bib-0021){ref-type="ref"}, [^22^](#jcla23412-bib-0022){ref-type="ref"}, [^23^](#jcla23412-bib-0023){ref-type="ref"}, [^24^](#jcla23412-bib-0024){ref-type="ref"}, [^25^](#jcla23412-bib-0025){ref-type="ref"}, [^26^](#jcla23412-bib-0026){ref-type="ref"}, [^27^](#jcla23412-bib-0027){ref-type="ref"}, [^28^](#jcla23412-bib-0028){ref-type="ref"} The main characteristics of the included studies are shown in Table [1](#jcla23412-tbl-0001){ref-type="table"}.

###### 

Characteristics of the included studies

<table><thead><tr class="header"><th>Author</th><th>Location</th><th>Age</th><th>Male</th><th>Severe/non‐survival</th><th>Non‐severe/survival</th><th></th><th></th><th></th><th></th></tr></thead><tbody><tr class="odd"><td>Peng Yudong et al<a href="#jcla23412-bib-0005" data-ref-type="ref"><sup>5</sup></a></td><td>China</td><td>62 (median)</td><td>53 (47.3)</td><td>16</td><td>NR</td><td><p>13.05 (mmol/L)</p><p>(9.4‐16.65)</p></td><td>96</td><td>NR</td><td><p>11.4 (mmol/L)</p><p>(8.7‐14.8)</p></td></tr><tr class="even"><td>Mo Pingzheng et al<a href="#jcla23412-bib-0006" data-ref-type="ref"><sup>6</sup></a></td><td>China</td><td>54 (median)</td><td>86 (55.5)</td><td>85</td><td>36 (32‐40)</td><td>NR</td><td>70</td><td>39 (36‐42)</td><td>NR</td></tr><tr class="odd"><td>Huang Chaolin et al<a href="#jcla23412-bib-0007" data-ref-type="ref"><sup>7</sup></a></td><td>China</td><td>49 (median)</td><td>30 (73.2)</td><td>13</td><td>27.9 (26.3‐30.9)</td><td><p>14 (mmol/L)</p><p>(11.9‐32.9)</p></td><td>28</td><td>34.7 (30.2‐36.5)</td><td><p>10.8 (mmol/L)</p><p>(9.4‐12.3)</p></td></tr><tr class="even"><td>Qian Guoqing et al<a href="#jcla23412-bib-0008" data-ref-type="ref"><sup>8</sup></a></td><td>China</td><td>50 (median)</td><td>37 (40.7)</td><td>9</td><td>38.55 (36.33‐39.25)</td><td>NR</td><td>82</td><td>40.2 (38‐42.4)</td><td>NR</td></tr><tr class="odd"><td>Wu Chaomin et al<a href="#jcla23412-bib-0009" data-ref-type="ref"><sup>9</sup></a></td><td>China</td><td>51 (median)</td><td>128 (63.7)</td><td>84</td><td>30.4 (27.15‐33.35)</td><td><p>12.9 (mg/dL)</p><p>(9.5‐17.05)</p></td><td>117</td><td>33.7 (30.95‐36.3)</td><td><p>10.5 (mg/dL)</p><p>(8.6‐13.65)</p></td></tr><tr class="even"><td>Liu Yanli et al<a href="#jcla23412-bib-0012" data-ref-type="ref"><sup>12</sup></a></td><td>China</td><td>55 (median)</td><td>59 (54.1)</td><td>53</td><td>NR</td><td><p>10.5 (mmol/L)</p><p>(6.2‐14.8)</p></td><td>56</td><td>NR</td><td><p>8.3 (mmol/L)</p><p>(6.8‐11.7)</p></td></tr><tr class="odd"><td>Li Jie et al<a href="#jcla23412-bib-0011" data-ref-type="ref"><sup>11</sup></a></td><td>China</td><td>45.1 (mean)</td><td>9 (52.9)</td><td>12</td><td>NR</td><td><p>19.3 (mmol/L)</p><p>± 14.8</p></td><td>5</td><td>NR</td><td><p>12.2 (mmol/L)</p><p>± 4.8</p></td></tr><tr class="even"><td>Liu Jing et al<a href="#jcla23412-bib-0013" data-ref-type="ref"><sup>13</sup></a></td><td>China</td><td>48.7 (mean)</td><td>15 (37.5)</td><td>13</td><td>NR</td><td><p>13.2 (μmol/L)</p><p>± 5.5</p></td><td>27</td><td>NR</td><td><p>8.8 (μmol/L)</p><p>± 4.1</p></td></tr><tr class="odd"><td>Liu Jingyuan et al<a href="#jcla23412-bib-0010" data-ref-type="ref"><sup>10</sup></a></td><td>China</td><td>40 (median)</td><td>31 (50.8)</td><td>17</td><td>43 (37‐45.5)</td><td>NR</td><td>44</td><td>44 (41‐47)</td><td>NR</td></tr><tr class="even"><td>Huang Huang et al<a href="#jcla23412-bib-0014" data-ref-type="ref"><sup>14</sup></a></td><td>China</td><td>44.87 (mean)</td><td>63 (50.4)</td><td>32</td><td>33.49 ± 4.79</td><td>NR</td><td>93</td><td>39.83 ± 4.49</td><td>NR</td></tr><tr class="odd"><td>Liu Min et al<a href="#jcla23412-bib-0015" data-ref-type="ref"><sup>15</sup></a></td><td>China</td><td>35 (mean)</td><td>10 (33.3)</td><td>4</td><td>35 ± 1.1</td><td>NR</td><td>26</td><td>42 ± 3.4</td><td>NR</td></tr><tr class="even"><td>Liu Wei et al<a href="#jcla23412-bib-0016" data-ref-type="ref"><sup>16</sup></a></td><td>China</td><td>38 (median)</td><td>39 (50.0)</td><td>11</td><td>36.62 ± 6.6</td><td>NR</td><td>67</td><td>41.27 ± 4.55</td><td>NR</td></tr><tr class="odd"><td>Ling Yun et al<a href="#jcla23412-bib-0017" data-ref-type="ref"><sup>17</sup></a></td><td>China</td><td>49.9 (mean)</td><td>154 (52.7)</td><td>21</td><td>35.8 ± 4.6</td><td>NR</td><td>271</td><td>40.9 ± 3.8</td><td>NR</td></tr><tr class="even"><td>Wang Dawei et al<a href="#jcla23412-bib-0028" data-ref-type="ref"><sup>28</sup></a></td><td>China</td><td>56 (median)</td><td>75 (54.3)</td><td>36</td><td>NR</td><td><p>11.5 (mmol/L)</p><p>(9.6‐18.6)</p></td><td>102</td><td>NR</td><td><p>9.3 (mmol/L)</p><p>(8.2‐12.8)</p></td></tr><tr class="odd"><td>Wang Feng et al<a href="#jcla23412-bib-0018" data-ref-type="ref"><sup>18</sup></a></td><td>China</td><td>68.6 (mean)</td><td>21 (75.0)</td><td>14</td><td>NR</td><td><p>15.8 (μmol/L)</p><p>± 6.8</p></td><td>14</td><td>NR</td><td><p>9.1 (μmol/L)</p><p>± 3.6</p></td></tr><tr class="even"><td>Zheng F. et al<a href="#jcla23412-bib-0019" data-ref-type="ref"><sup>19</sup></a></td><td>China</td><td>45 (median)</td><td>80 (49.7)</td><td>30</td><td>NR</td><td><p>12.7 (μmol/L)</p><p>(9.2‐16.9)</p></td><td>131</td><td>NR</td><td><p>10.7 (μmol/L)</p><p>(8.18‐15.3)</p></td></tr><tr class="odd"><td>Lei Shaoqing et al<a href="#jcla23412-bib-0020" data-ref-type="ref"><sup>20</sup></a></td><td>China</td><td>55 (median)</td><td>14 (41.2)</td><td>15</td><td>NR</td><td><p>13.0 (μmol/L)</p><p>(9.1‐19.2)</p></td><td>19</td><td>NR</td><td><p>8.1 (μmol/L)</p><p>(6.5‐12.9)</p></td></tr><tr class="even"><td>Yang Xiaobo et al<a href="#jcla23412-bib-0021" data-ref-type="ref"><sup>21</sup></a></td><td>China</td><td>59.7 (mean)</td><td>35 (67.0)</td><td>32</td><td>NR</td><td><p>19.5 (μmol/L)</p><p>± 11.6</p></td><td>20</td><td>NR</td><td><p>13.1 (μmol/L)</p><p>± 4.3</p></td></tr><tr class="odd"><td>Zhou Fei et al<a href="#jcla23412-bib-0022" data-ref-type="ref"><sup>22</sup></a></td><td>China</td><td>56 (median)</td><td>119 (62.0)</td><td>54</td><td>29.1 (26.5‐31.3)</td><td>NR</td><td>137</td><td>33.6 (30.6‐36.4)</td><td>NR</td></tr><tr class="even"><td>Ruan Qiurong et al<a href="#jcla23412-bib-0023" data-ref-type="ref"><sup>23</sup></a></td><td>China</td><td>NR</td><td>102 (68.0)</td><td>68</td><td>28.8 ± 3.8</td><td><p>18.1 (μmol/L)</p><p>± 10.7</p></td><td>82</td><td>32.7 ± 3.8</td><td><p>12.8 (μmol/L)</p><p>± 6.8</p></td></tr><tr class="odd"><td>Wang Yang et al<a href="#jcla23412-bib-0024" data-ref-type="ref"><sup>24</sup></a></td><td>China</td><td>64 (median)</td><td>179 (52.0)</td><td>133</td><td>31 (28‐34)</td><td><p>12.9 (mmol/L)</p><p>(9.8‐19.2)</p></td><td>211</td><td>36 (33‐39)</td><td><p>8.5 (mmol/L)</p><p>(6.3‐11.3)</p></td></tr><tr class="even"><td>Wu Chaomin et al <a href="#jcla23412-bib-0009" data-ref-type="ref"><sup>9</sup></a></td><td>China</td><td>58.5 (median)</td><td>60 (71.4)</td><td>44</td><td>29.1 (26.2‐31.55)</td><td><p>14.5 (mg/dL)</p><p>(10.35‐19.8)</p></td><td>40</td><td>31.35 (27.7‐34.2)</td><td><p>11.65 (mg/dL)</p><p>(9.33‐15.15)</p></td></tr><tr class="odd"><td>Tomlins Jennifer et al<a href="#jcla23412-bib-0025" data-ref-type="ref"><sup>25</sup></a></td><td>US</td><td>75 (median)</td><td>60 (63.0)</td><td>20</td><td>30 (24‐32)</td><td>NR</td><td>75</td><td>32 (27‐36)</td><td>NR</td></tr><tr class="even"><td>Wang Dawei et al<a href="#jcla23412-bib-0026" data-ref-type="ref"><sup>26</sup></a></td><td>China</td><td>51 (median)</td><td>57 (53.3)</td><td>19</td><td>NR</td><td><p>11.3 (mmol/L)</p><p>(9.4‐20.7)</p></td><td>88</td><td>NR</td><td><p>9.5 (mmol/L)</p><p>(8.4‐12.9)</p></td></tr><tr class="odd"><td>Wang Kun et al<a href="#jcla23412-bib-0027" data-ref-type="ref"><sup>27</sup></a></td><td>China</td><td>NR</td><td>140 (47.3)</td><td>19</td><td>NR</td><td><p>10.2 (μmol/L)</p><p>(5.9‐17)</p></td><td>277</td><td>NR</td><td><p>8.2 (μmol/L)</p><p>(5.5‐11.8)</p></td></tr></tbody></table>

All values are n (%), median (IQR), or mean ± SD.

Abbreviation: NR, not reported.
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A total of 2948 COVID‐19 patients, totaling in 24 studies, reported albumin values or total bilirubin values, of these, 1713 patients in 17 studies were divided into severe and non‐severe groups, and 1319 patients in 8 studies were divided into non‐survival and survival groups. The pooled WMD indicated that the albumin values were significantly lower in COVID‐19 patients with the severe disease than in those without by using a random‐effects model (WMD = −4.39 g/L, 95% CI: −5.64, −3.15; *P* \< .001; *I* ^2^ = 70.2%, *P* = .001) (Figure [1A](#jcla23412-fig-0001){ref-type="fig"}). The result of SMD showed that total bilirubin values were considerably higher in COVID‐19 patients with the severe disease than in those without by using a fixed‐effects model (SMD = 0.51, 95% CI: 0.36, 0.66; *P* \< .001; *I* ^2^ = 10.9%, *P* = .343) (Figure [1B](#jcla23412-fig-0001){ref-type="fig"}). The changes of albumin levels and total bilirubin levels in non‐survival patients versus survival patients were similar to that in severe patients versus non‐severe patients by using a random‐effects model (Albumin WMD = −4.06 g/L, 95% CI: −4.98, −3.14; *P* \< .001; *I* ^2^ = 49.2%, *P* = .096. Total bilirubin SMD = 0.71, 95% CI: 0.50, 0.91; *P* \< .001; *I* ^2^ = 38.6%, *P* = .149) (Figure [1C,D](#jcla23412-fig-0001){ref-type="fig"}). No publication bias was found by Egger\'s test (all *P* \> .05) and Begg\'s test (all *P* \> .05).

![Forest plots of albumin values (A) and total bilirubin values (B) in severity patients with COVID‐19, and forest plots of albumin values (C) and total bilirubin values (D) in mortality patients with COVID‐19](JCLA-34-e23412-g001){#jcla23412-fig-0001}

Our results demonstrated that there were significant differences in albumin values and total bilirubin values in COVID‐19 patients with varying degrees of disease severity, suggesting that alterations in these two biomarkers' values can predict changes in the patients' condition. Besides, studies have shown that patients with COVID‐19 have elevated alanine aminotransferase and aspartate aminotransferase values,[^29^](#jcla23412-bib-0029){ref-type="ref"} suggesting that patients with COVID‐19 may have liver damage. Our results also supported this notion that COVID‐19 infection could cause liver damage in other aspects to a certain extent. However, the majority of patients in the included studies came from China, and the sample size was limited. Further analyses including more studies are needed to verify our findings.
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